Advertisement

Precision medicine for developmental and epileptic encephalopathies in Africa—strategies for a resource-limited setting

Published:December 08, 2022DOI:https://doi.org/10.1016/j.gim.2022.11.002

      Abstract

      Purpose

      Sub-Saharan Africa bears the highest burden of epilepsy worldwide. A presumed proportion is genetic, but this etiology is buried under the burden of infections and perinatal insults in a setting of limited awareness and few options for testing. Children with developmental and epileptic encephalopathies (DEEs) are most severely affected by this diagnostic gap in Africa, because the rate of actionable findings is highest in DEE-associated genes.

      Methods

      We tested 234 genetically naive South African children diagnosed with/possible DEE using gene panels, exome sequencing, and chromosomal microarray. Statistical comparison of electroclinical features in children with and children without candidate variants was performed to identify characteristics most likely predictive of a positive genetic finding.

      Results

      Of the 41 (of 234) children with likely/pathogenic variants, 26 had variants supporting precision therapy. Multivariate regression modeling highlighted neonatal or infantile-onset seizures and movement abnormalities as predictive of a positive genetic finding. We used this, coupled with an emphasis on precision medicine outcomes, to propose the pragmatic “Think-Genetics” strategy for early recognition of a possible genetic etiology.

      Conclusion

      Our findings emphasize the importance of an early genetic diagnosis in DEE. We designed the Think-Genetics strategy for early recognition, appropriate interim management, and genetic testing for DEE in resource-constrained settings.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      ACMG Member Login

      Are you an ACMG Member? Sign in for online access.

      Subscribe:

      Subscribe to Genetics in Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • World Health Organization
        World health statistics 2022: monitoring health for the SDGs, sustainable development goals. World Health Organization.
        (Published May 19, 2022)
        • Begley C.
        • Wagner R.G.
        • Abraham A.
        • et al.
        The global cost of epilepsy: a systematic review and extrapolation.
        Epilepsia. 2022; 63: 892-903https://doi.org/10.1111/epi.17165
      1. Intersectoral global action plan on epilepsy and other neurological disorders.
        • Ngugi A.K.
        • Kariuki S.M.
        • Bottomley C.
        • Kleinschmidt I.
        • Sander J.W.
        • Newton C.R.
        Incidence of epilepsy: a systematic review and meta-analysis.
        Neurology. 2011; 77: 1005-1012https://doi.org/10.1212/WNL.0b013e31822cfc90
        • Esterhuizen AI Carvill G.L.
        • Ramesar R.S.
        • et al.
        Clinical application of epilepsy genetics in Africa: is now the time?.
        Front Neurol. 2018; 9: 276https://doi.org/10.3389/fneur.2018.00276
        • Kwon C.S.
        • Wagner R.G.
        • Carpio A.
        • Jetté N.
        • Newton C.R.
        • Thurman D.J.
        The worldwide epilepsy treatment gap: a systematic review and recommendations for revised definitions – A report from the ILAE Epidemiology Commission.
        Epilepsia. 2022; 63: 551-564https://doi.org/10.1111/epi.17112
        • Raga S.
        • Specchio N.
        • Rheims S.
        • Wilmshurst J.M.
        Developmental and epileptic encephalopathies: recognition and approaches to care.
        Epileptic Disord. 2021; 23: 40-52https://doi.org/10.1684/epd.2021.1244
        • Palmer E.E.
        • Sachdev R.
        • Macintosh R.
        • et al.
        Diagnostic yield of whole genome sequencing after nondiagnostic exome sequencing or gene panel in developmental and epileptic encephalopathies.
        Neurology. 2021; 96: e1770-e1782https://doi.org/10.1212/WNL.0000000000011655
        • Bayat A.
        • Bayat M.
        • Rubboli G.
        • Møller R.S.
        Epilepsy syndromes in the first year of life and usefulness of genetic testing for precision.
        Genes (Basel). 2021; 12: 1051https://doi.org/10.3390/genes12071051
        • Sánchez Fernández I.
        • Loddenkemper T.
        • Gaínza-Lein M.
        • Sheidley B.R.
        • Poduri A.
        Diagnostic yield of genetic tests in epilepsy: a meta-analysis and cost-effectiveness study.
        Neurology. 2019; 92: e418-e428https://doi.org/10.1212/WNL.0000000000006850
      2. Brunklaus A, Feng T, Brünger T, et al. Gene variant effects across sodium channelopathies predict function and guide precision therapy. Brain. Published online January 17, 2022. http://doi.org/10.1093/brain/awac006

        • Knowles J.K.
        • Helbig I.
        • Metcalf C.S.
        • et al.
        Precision medicine for genetic epilepsy on the horizon: recent advances, present challenges and suggestions for continued progress.
        Epilepsia. 2022; 63: 2461-2475https://doi.org/10.1111/epi.17332
        • Sala-Coromina J.
        • Raspall-Chaure M.
        • Marcé-Grau A.
        • de la Ossa A.M.
        • Macaya A.
        Early-onset eyelid stereotypies are a frequent and distinctive feature in Dravet syndrome.
        Seizure. 2021; 92: 155-157https://doi.org/10.1016/j.seizure.2021.08.020
        • Johannesen K.M.
        • Liu Y.
        • Koko M.
        • et al.
        Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.
        Brain. 2022; 145: 2991-3009https://doi.org/10.1093/brain/awab321
        • Wilmshurst J.M.
        • Reynolds L.
        • Van Toorn R.
        • Leisegang F.
        • Henderson H.E.
        Spinal muscular atrophy in black South Africans: concordance with the universal SMN1 genotype.
        Clin Genet. 2002; 62: 165-168https://doi.org/10.1034/j.1399-0004.2002.620210.x
        • Esterhuizen A.I.
        • Mefford H.C.
        • Ramesar R.S.
        • Wang S.
        • Carvill G.L.
        • Wilmshurst J.M.
        Dravet syndrome in South African infants: tools for an early diagnosis.
        Seizure. 2018; 62: 99-105https://doi.org/10.1016/j.seizure.2018.09.010
        • Harris P.A.
        • Taylor R.
        • Thielke R.
        • Payne J.
        • Gonzalez N.
        • Conde J.G.
        Research Electronic Data Capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support.
        J Biomed Inform. 2009; 42: 377-381https://doi.org/10.1016/j.jbi.2008.08.010
        • Hiatt J.B.
        • Pritchard C.C.
        • Salipante S.J.
        • O’Roak B.J.
        • Shendure J.
        Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation.
        Genome Res. 2013; 23: 843-854https://doi.org/10.1101/gr.147686.112
        • Carvill G.L.
        • Heavin S.B.
        • Yendle S.C.
        • et al.
        Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.
        Nat Genet. 2013; 45: 825-830https://doi.org/10.1038/ng.2646
        • Carvill G.L.
        • McMahon J.M.
        • Schneider A.
        • et al.
        Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonic-atonic seizures.
        Am J Hum Genet. 2015; 96: 808-815https://doi.org/10.1016/j.ajhg.2015.02.016
        • O’Roak B.J.
        • Vives L.
        • Fu W.
        • et al.
        Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.
        Science. 2012; 338: 1619-1622https://doi.org/10.1126/science.1227764
        • Richards S.
        • Aziz N.
        • Bale S.
        • et al.
        Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
        Genet Med. 2015; 17: 405-424https://doi.org/10.1038/gim.2015.30
        • Riggs E.R.
        • Andersen E.F.
        • Cherry A.M.
        • et al.
        Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).
        Genet Med. 2020; 22 (Published correction appears in Genet Med. 2021;23(11):2230. http://doi.org/10.1038/s41436-019-0686-8): 245-257
        • Chong J.X.
        • Burrage L.C.
        • Beck A.E.
        • et al.
        Autosomal-dominant multiple pterygium syndrome is caused by mutations in MYH3.
        Am J Hum Genet. 2015; 96: 841-849https://doi.org/10.1016/j.ajhg.2015.04.004
        • Karczewski K.J.
        • Francioli L.C.
        • Tiao G.
        • et al.
        The mutational constraint spectrum quantified from variation in 141,456 humans.
        Nature. 2020; 581 (Published correction appears in Nature. 2021;590(7846):E53. Published correction appears in Nature. 2021;597(7874):E3-E4. http://doi.org/10.1038/s41586-020-2308-7): 434-443
        • Mitter D.
        • Pringsheim M.
        • Kaulisch M.
        • et al.
        FOXG1 syndrome: genotype–phenotype association in 83 patients with FOXG1 variants.
        Genet Med. 2018; 20: 98-108https://doi.org/10.1038/gim.2017.75
        • Demarest S.T.
        • Olson H.E.
        • Moss A.
        • et al.
        CDKL5 deficiency disorder: relationship between genotype, epilepsy, cortical visual impairment, and development.
        Epilepsia. 2019; 60: 1733-1742https://doi.org/10.1111/epi.16285
        • Mulhern M.S.
        • Stumpel C.
        • Stong N.
        • et al.
        NBEA: developmental disease gene with early generalized epilepsy phenotypes.
        Ann Neurol. 2018; 84: 788-795https://doi.org/10.1002/ana.25350
        • Manole A.
        • Efthymiou S.
        • O’Connor E.
        • et al.
        De novo and bi-allelic pathogenic variants in NARS1 cause neurodevelopmental delay due to toxic gain-of-function and partial loss-of-function effects.
        Am J Hum Genet. 2020; 107: 311-324https://doi.org/10.1016/j.ajhg.2020.06.016
        • Sobreira N.
        • Schiettecatte F.
        • Valle D.
        • Hamosh A.
        GeneMatcher: a matching tool for connecting investigators with an interest in the same gene.
        Hum Mutat. 2015; 36: 928-930https://doi.org/10.1002/humu.22844
        • Oates S.
        • Tang S.
        • Rosch R.
        • et al.
        Incorporating epilepsy genetics into clinical practice: a 360° evaluation.
        NPJ Genom Med. 2018; 3: 13https://doi.org/10.1038/s41525-018-0052-9
        • Lindy A.S.
        • Stosser M.B.
        • Butler E.
        • et al.
        Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders.
        Epilepsia. 2018; 59: 1062-1071https://doi.org/10.1111/epi.14074
        • Heyne H.O.
        • Singh T.
        • Stamberger H.
        • et al.
        De novo variants in neurodevelopmental disorders with epilepsy.
        Nat Genet. 2018; 50: 1048-1053https://doi.org/10.1038/s41588-018-0143-7
        • Willimsky E.K.
        • Munzig A.
        • Mayer K.
        • et al.
        Next generation sequencing in pediatric epilepsy using customized panels: size matters.
        Neuropediatrics. 2021; 52: 92-97https://doi.org/10.1055/s-0040-1712488
        • Symonds J.D.
        • McTague A.
        Epilepsy and developmental disorders: next generation sequencing in the clinic.
        Eur J Paediatr Neurol. 2020; 24 (Published correction appears in Eur J Paediatr Neurol. 2021;30:170. http://doi.org/10.1016/j.ejpn.2019.12.008): 15-23
        • Hoelz H.
        • Herdl C.
        • Gerstl L.
        • et al.
        Impact on clinical decision making of next-generation sequencing in pediatric epilepsy in a tertiary epilepsy referral center.
        Clin EEG Neurosci. 2020; 51: 61-69https://doi.org/10.1177/1550059419876518
        • Heyne H.O.
        • Artomov M.
        • Battke F.
        • et al.
        Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy.
        Genet Med. 2019; 21: 2496-2503https://doi.org/10.1038/s41436-019-0531-0
        • Allen A.S.
        • et al.
        • Epi4K Consortium, Epilepsy Phenome/Genome Project
        De novo mutations in epileptic encephalopathies.
        Nature. 2013; 501: 217-221https://doi.org/10.1038/nature12439
        • Liu J.
        • Tong L.
        • Song S.
        • et al.
        Novel and de novo mutations in pediatric refractory epilepsy.
        Mol Brain. 2018; 11 (Published correction appears in Mol Brain. 2018;11(1):59. http://doi.org/10.1186/s13041-018-0392-5): 48
        • Richter L.M.
        • Desmond C.
        Targeting AIDS orphans and child-headed households? A perspective from national surveys in South Africa, 1995-2005.
        AIDS Care. 2008; 20: 1019-1028https://doi.org/10.1080/09540120701842738
        • Mefford H.C.
        The road to diagnosis: shortening the diagnostic odyssey in epilepsy.
        Epilepsy Curr. 2019; 19: 307-309https://doi.org/10.1177/1535759719871593
        • Helbig I.
        • Ellis C.A.
        Personalized medicine in genetic epilepsies – possibilities, challenges, and new frontiers.
        Neuropharmacology. 2020; 172107970https://doi.org/10.1016/j.neuropharm.2020.107970
        • Howell K.B.
        • Eggers S.
        • Dalziel K.
        • et al.
        A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy.
        Epilepsia. 2018; 59: 1177-1187https://doi.org/10.1111/epi.14087